Journal of the National Cancer Institute
Testing those diagnosed with a disease is the most efficient way to identify carriers of predisposing germline genetic variants, and is consistent with clinical practice guidelines. To achieve the goal of genetically targeted primary disease prevention, testing for an identified familial pathogenic variant must then extend to disease-free relatives in a process known as "cascade testing".
One in 40 Ashkenazi Jews has a gene mutation that drastically increases the chance of certain cancers — and Gail Fisher thinks people need to know about it.
Comprehensive Genomic Characterization of Breast Tumors with BRCA1 and BRCA2 Mutations
Germline mutations in the BRCA1 and BRCA2 genes predispose carriers to breast and ovarian cancer, and there remains a need to identify the specific genomic mechanisms by which cancer evolves in these patients. Here we present a systematic genomic analysis of breast tumors with BRCA1 and BRCA2 mutations, comparing these to common types of sporadic breast tumors.
Beyond The Headlines
This week's edition of "Beyond the Headlines" focuses on cancer. Do you know whether or not you are at greater risk of cancer due to a genetic mutation? It's not something we think about until we have a family member or a loved one who has been diagnosed with cancer.
Belt It Out For BRCA!
The BRCA Foundation presents its inaugural San Francisco fundraiser, Belt It Out For BRCA! A Night at the Piano Bar. The evening will include an elegant dinner, dueling pianists, live auction items, mystery boxes and more! Guests are invited to sing along to classic songs.
The BRCA Foundation is thrilled to announce a new Podcast called "Positive Perspectives," an empowering and informative series of weekly conversations about hereditary cancer. We speak with survivors, "previvors," doctors, scientists, genetic counselors, and advocates.
San Francisco Business Times
BRCA Foundation Co-Founder Evan Goldberg Talks with BioFlash podcaster and SF Business Times Biotech Reporter Ron Leuty on why he is compelled to support cancer research, and what is on the horizon in the effort to prevent, treat and cure genetic cancers.
Cancer might be in your DNA. How does a BRCA mutation affect the risk of cancer for both men and women? How are genetic cancers different than other cancers, and who should be tested? Click below for our April 12 panel discussion at the Commonwealth Club of San Francisco.
Our founder, Evan Goldberg was featured in the GENTRY MAGAZINE's series "Secrets to Their Success" as one of 'ten fascinating Bay Area men who discuss life, love, career, and the pursuit of happiness.' Evan talks about his decision to fund research to "help create a world…
The V Foundation for Cancer Research, one of the leading funders of cancer research in the United States, is partnering with the San Francisco-based BRCA Foundation and the Gray Foundation to fund research of cancers that derive from BRCA mutations.
Less than a year since it was founded, the BRCA Foundation has already done an impressive job of matching its commitment to helping uncover new options for cancer treatment with a solid track record of philanthropy. Established in early 2016 by NetSuite founder…
Fred Hutch News
Shortly after Dr. Kristin Anderson was diagnosed with triple negative breast cancer at the tender age of 28, she discovered something else. Years earlier, her aunt had also had breast cancer, triggered by a faulty BRCA1 gene. Anderson had genetic testing done and she learned…
San Francisco Business Times
The (Color) test typically costs $249, but the BRCA Foundation partnership lowers that price to $50. The test, available in more than 150 countries, can spot risks of several other cancers, including colorectal, pancreatic, prostate, stomach and uterine cancers and melanoma.
San Francisco Chronicle
This lets them (patients) take charge of health and lets researcher have greater access to patients for these studies,” said Evan Goldberg, co-founder of the BRCA Foundation, a collaboration among UCSF, Stanford and Harvard, including the latter’s affiliated Dana-Farber Cancer Institute.
Color Genomics announced the Color Family Testing Program to offer genetic testing to parents, siblings, and adult children of patients with hereditary cancer mutations for $50 instead of $249. The program is supported by donations from the BRCA Foundation and private donors.
Parents, siblings, and adult children are eligible to take a Color test. A relative of someone with a BRCA mutation, for example, has a 50% chance of having the mutation, too, which can lead to breast or ovarian cancer. Color has partnered with the BRCA Foundation and private…
Color Genomics is teaming up with the BRCA Foundation to launch a BRCA gene registry, so that people who have the BRCA mutations can opt in and be contacted for future research or clinical trials. The genetics testing company just raised another $45 million to help…
He is not the first Silicon Valley entrepreneur to get involved in cancer research, but to Evan M. Goldberg, founder, chair and chief technology officer of integrated cloud-based business solutions provider Netsuite, the battle against this menace is a very personal matter.
Goldberg, founder and chief technology officer of Silicon Valley-based NetSuite, a leading provider of cloud-based business management software, has discovered that he is a carrier of the BRCA gene mutation. BRCA gene mutations significantly heighten the risk of…
Malaya Business Insight
NetSuite’s founder and CTO Evan Goldberg and wife Cindy takes command of the BRCA Foundation, a philanthropic effort of the couple aimed at studying and finding cures to cancer. BRCA gene mutations significantly heighten the risk of developing or passing along…
San Francisco Business Times
Evan Goldberg’s life changed six years ago — and with the help of two young Bay Area life sciences companies and a national network of cancer researchers, the founder of business software company NetSuite Inc. hopes to change the lives of thousands more…
A Silicon Valley entrepreneur is giving a big boost to cancer research by making it his personal advocacy to support studies on gene mutations and BRCA cancers. NetSuite founder and chief technology officer Evan Goldberg announced recently that he is making a $10M…
Netsuite founder Evan Goldberg hopes the lessons he’s learned from building a software company can help researchers find new ways to treat cancers. When Netsuite founder Evan Goldberg was contacted by his birth mother it was not all good news, she revealed…
The Jewish News Weekly of Northern California
Evan Goldberg, founder and chief technology officer of San Mateo-based NetSuite, began doing philanthropic work after his company went public in 2008. Some of his efforts went toward cancer research — and that was before he discovered he was a carrier of the BRCA1…
San Francisco Chronicle
NetSuite co-founder Evan Goldberg, who was adopted shortly after birth, had never heard of the BRCA mutation until his birth mother contacted him about 15 years ago. A two-time breast cancer survivor, she had tested positive for one of two genetic abnormalities in the genes…
Imagine a world where individuals and families are free of the threat of BRCA cancers. Where a positive BRCA test does not inspire fear but instead the confidence that prevention and treatment are simple and effective.
Please Join Us
Make a Donation Today
and together we can create a world free of BRCA cancers tomorrow.
To date, the Foundation has made transformational grants at Stanford University, Harvard University and UCSF, and we are continually researching new partnership opportunities across the country. Most important: 100% of funds go directly to research.
We know it is possible. We know that cutting-edge scientific research being done today will bring about the therapies, cures and preventative treatments that will save the lives – and improve the quality of life – of millions of BRCA-positive individuals tomorrow.